The Mylan EpiPen Debacle: How Tremendous Greed Can Lead to the Demise of a Leader
N2Growth Blog
AUGUST 30, 2016
As you have likely heard, the pharmaceutical company Mylan and its CEO, Heather Bresch, have come under immense scrutiny for the firm’s EpiPen pricing policy. ” This coming from a person whose pay increased by over 670% in her tenure as CEO. peanuts, shellfish, insect bites etc.).
Let's personalize your content